Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives
Molecules · 03.03.2023 · 28 (5) · 2349
DOI: 10.3390/molecules28052349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 03.03.2023. Verfasst von Dorota Łażewska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Krakó…. Hauptthemen laut MEDLINE: Receptors, Histamine H3, Neuroblastoma, Alzheimer Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Jagiellonian University Medical College in Kraków, agiellonian University Medical College in Kraków.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disorder, for which there is no effective cure. Current drugs only slow down the course of the disease, and, therefore, there is an urgent need to find effective therapies that not only treat, but also prevent it. Acetylcholinesterase inhibitors (AChEIs), among others, have been used for years to treat AD. Histamine H3 receptors (H3Rs) antagonists/inverse agonists are indicated for CNS diseases. Combining AChEIs with H3R antagonism in one structure could bring a beneficial therapeutic effect. The aim of this study was to find new multitargetting ligands. Thus, continuing our previous research, acetyl- and propionyl-phenoxy-pentyl(-hexyl) derivatives were designed. These compounds were tested for their affinity to human H3Rs, as well as their ability to inhibit cholinesterases (acetyl- and butyrylcholinesterases) and, additionally, human monoamine oxidase B (MAO B). Furthermore, for the selected active compounds, their toxicity towards HepG2 or SH-SY5Y cells was evaluated. The results showed that compounds 16 (1-(4-((5-(azepan-1-yl)pentyl)oxy)phenyl)propan-1-one) and 17 (1-(4-((6-(azepan-1-yl)hexyl)oxy)phenyl)propan-1-one) are the most promising, with a high affinity for human H3Rs (Ki: 30 nM and 42 nM, respectively), a good ability to inhibit cholinesterases (16: AChE IC50 = 3.60 µM, BuChE IC50 = 0.55 µM; 17: AChE IC50 = 1.06 µM, BuChE IC50 = 2.86 µM), and lack of cell toxicity up to 50 µM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.
- Department of Physicochemical Drug Analysis, Jagiellonian University Medical College in Kraków, Medyczna 9, 30-688 Kraków, Poland.
- Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitaetsstr. 1, 40225 Düuesseldorf, Germany.
ORCID-Profile: Dorota Łażewska, Justyna Godyń, Mariam Dubiel, Ewelina Honkisz-Orzechowska, Anna Więckowska, Holger Stark, Katarzyna Kieć-Kononowicz
Förderung
- Deutsche Forschungsgemeinschaft
- Jagiellonian University Medical College in Kraków
- agiellonian University Medical College in Kraków
- DFG
Zitieren
APA
Łażewska, D., Kaleta, M., Zaręba, P., Godyń, J., Dubiel, M., Honkisz-Orzechowska, E., Doroz-Płonka, A., Więckowska, A., Stark, H., & Kieć-Kononowicz, K. (2023). Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives. Molecules, 28(5), 2349. https://doi.org/10.3390/molecules28052349
Vancouver
Łażewska D, Kaleta M, Zaręba P, Godyń J, Dubiel M, Honkisz-Orzechowska E, et al. Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives. Molecules. 2023;28(5):2349. doi:10.3390/molecules28052349
BibTeX
@article{aewska2023,
author = {Łażewska, Dorota and Kaleta, Maria and Zaręba, Paula and Godyń, Justyna and Dubiel, Mariam and Honkisz-Orzechowska, Ewelina and Doroz-Płonka, Agata and Więckowska, Anna and Stark, Holger and Kieć-Kononowicz, Katarzyna},
title = {Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives},
journal = {Molecules},
year = {2023},
volume = {28},
number = {5},
pages = {2349},
doi = {10.3390/molecules28052349}
}
EUVIMED